Australia's Atomo Diagnostics rises on NZ govt approval for COVID-19 antigen test

Atomo Diagnostics

27/01/2022 24:53

** Shares of Atomo Diagnostics Ltd  AT1.AX  rise as much as
25% to A$0.250, the biggest intraday pct gain since Dec 29
    ** The medical device co says that its COVID-19 antigen test
has received approval from the New Zealand Ministry of Health
for testing use  urn:newsml:reuters.com:*:nASN0022JX
    ** Says approval covers professional or self-test use and
authorised people are permitted to supply, distribute and sell
the COVID-19 antigen test in New Zealand
    ** Shares hit highest level since Jan 19 
    ** Stock down 1.64% in 2021
    

 (Reporting by Archishma Iyer)
 ((Archishma.Iyer@thomsonreuters.com;))